| GOLDMAN SACHS US CORE EQUITY PORTFOLIO I (SNAP) USD DIS | RVI USA | 8,45% | 48,78% | 96,96% | 228,32% |
| GOLDMAN SACHS US CORE EQUITY PORTFOLIO R (SNAP) GBP DIS | RVI USA | 7,79% | 48,27% | 96,75% | 228,24% |
| POLAR CAPITAL BIOTECHNOLOGY R USD DIS | BIOTECNOLOGÍA | 18,37% | 35,55% | 63,17% | 228,24% |
| BGF WORLD GOLD A2 CHF (HEDGED) | MATERIAS PRIMAS | 88,44% | 180,63% | 78,19% | 228,22% |
| GOLDMAN SACHS US CORE EQUITY PORTFOLIO R (SNAP) USD DIS | RVI USA | 8,45% | 48,74% | 96,91% | 228,20% |
| GOLDMAN SACHS JAPAN EQUITY PARTNERS PORTFOLIO R H EUR CAP | RVI JAPÓN | 11,63% | 80,20% | 100,74% | 228,04% |
| CT (LUX) GLOBAL FOCUS AE EUR | RVI GLOBAL | 8,48% | 48,08% | 71,21% | 227,99% |
| LYXOR EURO STOXX 50 DAILY (2X) LEVERAGED UCITS ETF ACC | RV EURO | 28,75% | 166,61% | 207,44% | 227,86% |
| POLAR CAPITAL BIOTECHNOLOGY R GBP DIS | BIOTECNOLOGÍA | 17,39% | 34,26% | 62,79% | 227,83% |
| CT (LUX) GLOBAL FOCUS AU USD | RVI GLOBAL | 9,40% | 48,80% | 71,77% | 227,81% |
